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Blood pressure and mortality: 
using offspring blood pressure 
as an instrument for own blood 
pressure in the HUNT study
Kaitlin H Wade1,2, David Carslake1,2, Tom Ivar Nilsen3, Nicholas J Timpson1,2,  
George Davey Smith1,2,* & Pål Romundstad3,*
Given that observational associations may be inaccurate, we used offspring blood pressure (BP) to 
provide alternative estimates of the associations between own BP and mortality. Observational 
associations between BP and mortality, estimated as hazard ratios (HRs) from Cox regression, were 
compared to HRs obtained using offspring BP as an instrumental variable (IV) for own BP (N = 32,227 
mother-offspring and 27,535 father-offspring pairs). Observationally, there were positive associations 
between own BP and mortality from all-causes, cardiovascular disease (CVD), coronary heart disease 
(CHD), stroke and diabetes. Point estimates of the associations between BP and mortality from all-
causes, CVD and CHD were amplified in magnitude when using offspring BP as an IV. For example, 
the HR for all-cause mortality per standard deviation (SD) increase in own systolic BP (SBP) obtained 
in conventional observational analyses increased from 1.10 (95% CI: 1.09–1.12; P < 0.0001) to 1.31 
(95% CI: 1.19–1.43; P < 0.0001). Additionally, SBP was positively associated with diabetes and cancer 
mortality (HRs: 2.00; 95% CI: 1.12–3.35; P = 0.02 and 1.20; 95% CI: 1.02–1.42; P = 0.03, respectively), 
and diastolic BP (DBP) with stroke mortality (HR: 1.30; 95% CI: 1.02–1.66; P = 0.03). Results support 
positive associations between BP and mortality from all-causes, CVD, and CHD, SBP on cancer 
mortality, and DBP on stroke mortality.
High blood pressure (BP) is an increasingly important health problem. Studies over the last few decades 
have confirmed a relationship between high BP and adverse health outcomes, including mortality from 
all causes1–8, cancer9 and cardiovascular diseases (CVD)6, reported within individuals of varying age, 
socioeconomic status and ethnicity1–3,6,8. A large meta-analysis showed that a difference of 20 mmHg 
systolic BP (SBP) or 10 mmHg diastolic BP (DBP) was associated with more than a two-fold increase 
in the risk of death from stroke, ischemic heart disease (IHD) and other vascular causes6. Many rand-
omized controlled trials (RCTs) have shown that antihypertensive (BP lowering) medications, including 
thiazide diuretics, beta blockers, and angiotensin-converting enzyme (ACE) inhibitors, reduce the risk 
of developing CVD, coronary heart disease (CHD), stroke, and other vascular events and mortality10–13.
Existing literature is inconsistent in explaining the specific pattern of association of BP with all-cause 
and cause-specific mortality. Many studies have shown a U-shaped relationship, similar to the associ-
ation observed for body mass index (BMI) and mortality14–20, where individuals with either extremely 
low or high BP have the highest mortality. Furthermore, there is evidence suggesting an inverse or 
attenuated association between BP and mortality among the elderly4,14,21,22 and a moderate increase in 
mortality with antihypertensive treatment23, specifically for patients on dialysis24. Additionally, some 
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antihypertensive medications have been shown to increase type-2 diabetes risk25,26, which is itself associ-
ated with increased BP27,28. Therefore, it is unclear whether shifting the entire BP distribution downwards 
would reduce mortality in the whole population.
Most literature on the association between BP and mortality is based on observational analyses that 
are known to suffer from intractable biases, such as measurement error and confounding29, which may 
attenuate effect sizes or generate spurious results. For example, factors associated with both BP and mor-
tality, such as smoking, BMI, and socioeconomic status, may interfere with the association. Furthermore, 
conventional observational associations are vulnerable to reverse causation, where disease leading to 
mortality may also alter BP30. Statistical adjustment for confounding factors and methodological removal 
of deaths occurring shortly after baseline and the first period of follow-up are attempts to overcome such 
issues inherent to observational data31. However, error in BP measurement and unmeasured factors can 
lead to residual confounding32 and biased associations33. Consequently, more accurate and reliable esti-
mates of the association between BP and mortality are needed.
A methodological development for the assessment of causality is the application of instrumental var-
iables (IVs)31,34 within survival analyses. An IV is one that is associated with a risk factor (here, BP) and 
potentially with an outcome (here, mortality), but only through its association with the risk factor35. 
Additionally, the instrument is not influenced by the confounding factors of the risk factor-outcome 
association. Given these properties, the variance in a risk factor explained by the instrument provides an 
unbiased and unconfounded causal assessment of the association between the risk factor and outcome. 
Importantly for survival analyses, potentially fatal diseases that also affect BP (biasing conventional 
observational estimates of the effect of BP on mortality) will not be associated with a valid IV. One such 
application of IV analysis is the use of offspring exposures as instruments for parents’ own exposure 
(Fig.  1). This method has been applied to investigate the associations between BMI and mortality31, 
height and mortality36, and weight and employment disability34. The extent to which reverse causation 
influences the association between BP and mortality was reduced by using offspring exposures compared 
to own exposures31. We therefore used IV analysis to provide a more reliable estimate of the causal asso-
ciations between BP and mortality, using offspring BP as an instrument for own BP, in data from the 
Nord-Trøndelag health study (HUNT Study, Norway).
Results
Data were available for 32,227 mother-offspring pairs (8,907 maternal deaths) and 27,535 father-offspring 
pairs (9,633 paternal deaths). The residual standard deviation (SD) in SBP/DBP after adjustment 
for age and HUNT survey (used to scale SBP/DBP) was 17.53 mmHg/10.47 mmHg in women and 
16.57 mmHg/10.25 mmHg in men, respectively. Characteristics of included individuals are described in 
Table  1. Offspring SBP and DBP were positively associated with SBP and DBP of both mothers and 
fathers (Supplementary Tables S1 and S2, respectively). Parents with higher BP, as well as offspring them-
selves, had higher BMI, were less likely to have spent ten years in full time education and were more 
likely to be taking antihypertensive medication. Characteristics of offspring and parents according to 
maternal and paternal SBP/DBP were similar (Supplementary Tables S3/S4 and S5/S6, respectively).
Offspring versus own BP. Offspring and own SBP and DBP were positively associated with parental 
all-cause mortality and mortality from CVD, CHD and stroke (Tables 2 and 3). In each case, associations 
between own BP and all four primary outcomes were substantially stronger than those obtained with 
offspring BP.
IV analysis using offspring BP as an instrument for own BP. For combined parents, the denom-
inators in the IV process (regression coefficients between parental and offspring BP, adjusted for the 
same variables as the numerator and scaled by sex-specific SD scores) were 0.22 (SE = 0.01) and 0.17 
(SE = 0.005) for SBP and DBP, respectively. IV analysis showed positive associations between own BP 
(using offspring BP as an instrument) and mortality from all causes (HR per SD increase in BP: 1.28; 95% 
CI: 1.18–1.39; P < 0.0001 with SBP and 1.31; 95% CI: 1.19–1.43; P < 0.0001 with DBP), CVD (HR per 
SD increase in BP: 1.38; 95% CI: 1.23–1.54; P < 0.0001 with SBP and 1.46; 95% CI: 1.28–1.66; P < 0.0001 
with DBP), and CHD (HR per SD increase in BP: 1.32; 95% CI: 1.17–1.50; P < 0.0001 with SBP and 
1.38; 95% CI: 1.19–1.59; P < 0.0001 with DBP) (Table 2 and 3 for SBP and DBP, respectively). There was 
a positive association between own DBP and mortality from stroke (HR per SD increase in DBP: 1.30; 
95% CI: 1.02–1.66; P = 0.03), the estimate of which was smaller in magnitude with SBP (HR per SD 
increase in SBP: 1.21; 95% CI: 0.98–1.51; P = 0.08); however, the estimate was similar to that obtained 
in conventional observational analyses.
The HRs from IV regression were substantially greater than those from the corresponding conven-
tional Cox models for mortality from all causes (P = 0.0002 with SBP and P < 0.0001 with DBP), CVD 
(P = 0.01 with SBP and P = 0.001 with DBP) and CHD (P = 0.02 with SBP and P = 0.01 with DBP). HRs 
from IV and conventional Cox regression for stroke were very similar.
In secondary IV analyses, there were positive associations between own SBP and mortality from 
diabetes, cancer and pancreatic cancer, all HRs of which were greater than those obtained through con-
ventional Cox regression with either offspring or own SBP (Supplementary Tables S7/S8 for SBP/DBP, 
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respectively). The estimates of the associations between own DBP, instrumented by offspring DBP, and 
mortality from diabetes and cancer were greater (but with wider CIs) compared to conventional obser-
vational estimates.
Parent-specific analyses showed similar results (Supplementary Tables S9/S10 and S11/S12 for mater-
nal and paternal SBP/DBP, respectively).
Sensitivity analyses. Adjusting for BMI made little difference in most conventional Cox regressions 
(Supplementary Tables S13/S14 for SBP/DBP, respectively). However, the IV-estimated HRs for mortality 
from CHD increased slightly. In IV analyses, adjusting for BMI gave similar HRs for mortality from all 
causes and CVD.
Excluding individuals taking antihypertensive medication produced similar results (Supplementary 
Tables S15/S16 for SBP/DBP, respectively). However, the IV-estimated HRs for CVD mortality attenuated 
towards the null. IV-estimated HRs for all other primary causes of mortality were consistent with main 
results.
In secondary IV analyses, the HRs for diabetes mortality attenuated towards the null when adjust-
ing for BMI (HR per SD increase in BP: 1.79; 95% CI: 0.95–3.36; P = 0.07 with SBP and 1.72; 95% 
CI: 0.81–3.63; P = 0.16 with DBP). After excluding individuals taking antihypertensive medication, 
the  IV-estimated HRs for mortality from diabetes, cancer and pancreatic cancer with own SBP and 
the IV-estimated HRs for mortality from diabetes, respiratory diseases and colorectal cancer with DBP 
increased, although CIs became wider.
Figure 1. Diagram representing the underlying IV methodology employed in analyses using the 
example of assessing the association between SBP and CVD mortality. A) In observational epidemiology, 
the association between the exposure (here, own SBP (SBPown)) and an outcome of interest (here, own 
mortality from CVD (CVDown)) may be distorted due to confounding, bias and reverse causation. B) Using 
offspring SBP (SBPoff) as an instrument for SBPown (where SBPoff explains ~2.4% of the variance in SBPown) 
reduces the possibility of such limitations. Firstly, unlike observational analyses, the portion of variance 
in SBPown explained by SBPoff will not be directly affected by CVDown; therefore, reducing bias due to 
reverse causation. Secondly, the effect of potential confounding variables is reduced because they are less 
associated with SBPoff than they are with SBPown. Any remaining confounding due to the association between 
confounders and SBPoff can be further reduced by adjustment for shared and measured environmental 
confounders (dotted lines).
www.nature.com/scientificreports/
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Linearity of mortality using offspring and own BP. Due to differences in the SD of BP between 
men and women, conversion of units back from SD to mmHg led to slightly different values according 
to the sex of the individual. Therefore, the exposure scales for men and women in the cubic spline plots, 
although similar, are represented on the upper and lower x-axes, respectively. Assessment of linearity 
between own BP and most causes of mortality showed a U-shaped association. However, this pattern was 
not observed with offspring BP (Figs 2 and 3 for associations of SBP and DBP with all-cause mortality 
and mortality from CVD, CHD and stroke; Supplementary Figures S3-S8 for all mortality outcomes).
Subject, Measurement N
Mean (SD) or 
proportion
Offspring
 Age (years) 63,807 29.54 (10.94)
 Sex (% male) 66,262 51.15
 BMI (kg/m2) 63,578 24.14 (4.02)
 SBP (mmHg) 63,807 126.25 (14.53)
 DBP (mmHg) 63,807 75.02 (11.61)
 Proportion ever smoked (%) 57,940 41.92
  Proportion drinking ≥ 5 
times fortnightly (%) 43,823 4.11
  Proportion educated ≥ 10 
years (%) 37,420 72.07
  Proportion physically active 
(%) 38,167 90.68
  Proportion taking 
antihypertensives (%) 50,418 3.09
Mothers
 BMI (kg/m2) 61,163 25.53 (4.56)
 SBP (mmHg) 61,526 135.81 (25.03)
 DBP (mmHg) 61,526 82.60 (12.25)
 Age at child’s birth (years) 61,526 49.07 (16.17)
 Proportion ever smoked (%) 52,655 45.52
  Proportion drinking ≥ 5 
times fortnightly (%) 51,542 2.77
  Proportion educated ≥ 10 
years (%) 50,987 39.07
  Proportion physically active 
(%) 43,352 83.95
  Proportion taking 
antihypertensives (%) 61,491 15.35
Fathers
 BMI (kg/m2) 52,226 25.58 (3.23)
 SBP (mmHg) 52,452 140.04 (20.35)
 DBP (mmHg) 52,452 85.87 (11.28)
 Age at child’s birth (years) 52,452 50.33 (15.95)
 Proportion ever smoked (%) 45,111 64.11
  Proportion drinking ≥ 5 
times fortnightly (%) 44,109 8.20
  Proportion educated ≥ 10 
years (%) 42,990 45.98
  Proportion physically active 
(%) 36,726 84.46
  Proportion taking 
antihypertensives (%) 52,413 10.83
Table 1. Descriptive characteristics of the study population. BMI: body-mass index, CI: confidence 
interval, DBP: diastolic blood pressure, SBP: systolic blood pressure, SD: standard deviation.
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Discussion
This is the first large prospective study to use offspring BP as an instrument for own BP to obtain more 
reliable estimates of causal associations between BP and mortality, without the limitations inherent in 
conventional observational analyses. Results provided evidence to support positive causal associations 
between own BP and mortality from all causes, CVD and CHD; and own DBP and stroke mortality; and 
own SBP and mortality from cancer, pancreatic cancer and diabetes. IV-estimated HRs were larger than 
those obtained from conventional Cox regression, highlighting the potential confounding within con-
ventional observational associations. The positive association between own SBP and mortality from dia-
betes attenuated with adjustment for BMI, suggesting either mediation through BMI or an independent 
association between BMI and mortality from diabetes. The estimate of the positive association between 
own SBP and mortality from pancreatic cancer was found using IV but not in conventional observational 
analyses, suggesting that observational analyses may underestimate the causal relationship. However, the 
potential role of chance in this and other relatively weak associations such as those observed between 
own SBP and mortality from the various other cancers cannot be ruled out. When excluding individuals 
taking antihypertensive medication, HRs for a majority of mortality causes remained consistent with 
main analyses; however, the HR for CVD mortality attenuated towards the null, highlighting the poten-
tial overestimation of estimates owing to the use of antihypertensives.
Our main findings are consistent with previous studies showing an increased risk of all-cause mor-
tality and mortality from CVD and CHD with increasing BP1,2,5–8,10–12. Our results are also in line with 
many studies showing a positive association between hypertension and diabetes, which tend to occur 
simultaneously27,28, where the direction of causality is unclear. Our results suggest a causal association 
with increasing BP and an increased risk of diabetes mortality; however, there are many factors that may 
confound the association37,38. Upon adjustment for BMI in IV analyses, the HRs for diabetes mortality 
decreased, suggesting that parents’ BMI may be associated both with their own risk of diabetic mortality 
and with their offspring’s BP (probably via the offspring’s BMI)31. Our BMI-adjusted results are also 
consistent with the Prospective Studies Collaboration, which showed that individuals with a BMI above 
22.5–25 kg/m2 have an increased risk of diabetic, renal and vascular mortality39. Additionally, evidence 
on the effect on diabetes of strategies to reduce BP is inconclusive25–28. Although CIs widened, excluding 
Cause of Death Deaths
Offspring SBP, fully adjusted* Own SBP, fully adjusted* IV, fully adjusted* P-value for 
comparison 
with own SBPHR 95% CI P-value HR 95% CI P-value HR 95% CI P-value
All cause 18,540 1.05 (1.04–1.07) < 0.0001 1.11 (1.09–1.12) < 0.0001 1.28 (1.18–1.39) < 0.0001 0.0002
Cardiovascular Disease 8,772 1.07 (1.05–1.10) < 0.0001 1.19 (1.17–1.21) < 0.0001 1.38 (1.23–1.54) < 0.0001 0.01
Coronary Heart Disease 6,571 1.06 (1.03–1.09) < 0.0001 1.15 (1.13–1.17) < 0.0001 1.32 (1.17–1.50) < 0.0001 0.02
Stroke 2,268 1.04 (0.99–1.09) 0.08 1.22 (1.18–1.26) < 0.0001 1.21 (0.98–1.51) 0.08 0.95
Table 2. Adjusted HRs per SD of offspring SBP for combined parents and HRs for own SBP estimated 
by conventional observational and IV analyses. CI: confidence interval, HR: hazard ratio, IV: instrumental 
variable, SBP: systolic blood pressure, SD: standard deviation. *adjusted for age, sex and HUNT survey of 
offspring/parent from whom SBP was measured, offspring and parental smoking status, age, DOB, alcohol 
consumption, education, own and spouse’s employment, exercise and sex of parent.
Cause of Death Deaths
Offspring DBP, fully adjusted* Own DBP, fully adjusted* IV, fully adjusted*
P-value for 
comparison with 
own DBPHR 95% CI P-value HR 95% CI P-value HR 95% CI P-value
All cause 18,540 1.05 (1.03–1.06) < 0.0001 1.10 (1.09–1.12) < 0.0001 1.31 (1.19–1.43) < 0.0001 0.0001
Cardiovascular Disease 8,772 1.07 (1.04–1.09) < 0.0001 1.19 (1.16–1.21) < 0.0001 1.46 (1.28–1.66) < 0.0001 0.001
Coronary Heart Disease 6,571 1.06 (1.03–1.08) < 0.0001 1.14 (1.11–1.16) < 0.0001 1.38 (1.19–1.59) < 0.0001 0.01
Stroke 2,268 1.05 (1.00–1.09) 0.03 1.26 (1.21–1.31) < 0.0001 1.30 (1.02–1.66) 0.03 0.81
Table 3. Adjusted HRs per SD of offspring DBP for combined parents and HRs for own DBP estimated 
by conventional observational and IV analyses. CI: confidence interval, DBP: diastolic blood pressure, HR: 
hazard ratio, IV: instrumental variable, SD: standard deviation. *adjusted for age, sex and HUNT survey of 
offspring/parent from whom DBP was measured, offspring and parental smoking status, age, DOB, alcohol 
consumption, education, own and spouse’s employment, exercise and sex of parent.
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Figure 2. Fitted HRs (median SBP as a reference) from cubic spline models for selected mortality 
causes. Shaded areas represent 95% CI and vertical lines represent the 1st and 99th percentiles of systolic 
blood pressure (SBP). Although similar, the upper X-axis applies to male SBP and the lower X-axis to female 
SBP.
www.nature.com/scientificreports/
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Figure 3. Fitted HRs (median DBP as a reference) from cubic spline models for selected mortality 
causes. Shaded areas represent 95% CI and vertical lines represent the 1st and 99th percentiles of diastolic 
blood pressure (DBP). Although similar, the upper X-axis applies to male DBP and the lower X-axis to 
female DBP.
www.nature.com/scientificreports/
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individuals known to be taking antihypertensives in our analyses increased the IV HRs for mortality 
from diabetes.
Similar to the conventional observational associations found between own BP and mortality, pre-
vious studies have reported a U-shaped association between mortality and BP14–20; however, this was 
not supported when using offspring BP. As many of these studies used populations with a previous 
illness14–20, the nonlinear associations may be explained by the presence of such previous illnesses, which 
may potentially lower BP and increase risk of mortality, producing a reverse association. In fact, larger 
studies assessing the association between BP and mortality, which did adjust for baseline traits, provided 
more evidence for a linear relationship14–20. Our current finding supports this linear association, suggest-
ing that the U-shaped curve found in many observational studies may be due to reverse causation or 
confounding, underestimating the positive effect of elevated BP on mortality, but falsely overestimating 
the effect of low BP on mortality.
As previously discussed31, the avoidance of reverse causation depends on the IV satisfying some 
important assumptions. Of these, we showed that the instrument (here, offspring BP) was associated with 
the exposure (here, own BP). Secondly, the extent to which reverse causation influenced the association 
between BP and mortality was reduced by using offspring BP compared to own BP31. It is unlikely that 
fathers’ illness would directly affect offspring BP31; however, mothers’ illness (especially during preg-
nancy) may later influence fetal development, and thus BP. Therefore, confounding may still be present 
in such associations, specifically in mother-offspring pairs, if intrauterine exposures are associated with 
offspring BP (for example smoking during pregnancy has been shown to be associated with offspring 
BP during later life40,41). Such exposures are likely to lead to differences in mortality estimates between 
mother- and father-offspring pairs, which we do not observe. Additionally, the earliest available HUNT 
survey was used to maximise the period that parents were at risk and minimize the potential influence 
of illness-induced alterations to both offspring and own BP. Therefore, it is unlikely that the instrument 
was affected by the outcome.
Thirdly, although we could not test whether the instrument was independent of any residual (or 
unmeasured) confounding factors, or if there were any other pathways from the instrument to the out-
come directly (regardless of the exposure), reassuringly, the adjustment for measured potential con-
founders made little difference to results. Whilst the IV methodology used here cannot be considered 
gold standard for assessing causality, results add to existing literature within this context. Shared envi-
ronmental confounding, specifically between the instrument (here, offspring BP) and the outcome (mor-
tality), may still be a potentially confounding factor when using offspring measures as instruments for 
own measures. However, the inherent correlation between offspring and parental BP measures and likely 
differences in transgenerational environment would be more likely to break down confounding struc-
tures and reduce bias in these analyses, and as such be an improvement to observational measures alone. 
Finally, although it is often difficult to refute the existence of independent pathways from the instrument 
to the outcome, it is unlikely that offspring BP could directly affect parental mortality.
Although we adjusted participants’ BP for the treatment effect of antihypertensives, and performed a 
sensitivity analysis excluding individuals taking such medication, there may have been antihypertensive 
use at baseline or measurement error (as antihypertensive use was self-reported).
Contrary to previous reports of U-shaped associations between BP and mortality, this pattern was 
observed for own BP, but not for offspring BP, suggesting that the causal association between BP and 
mortality is approximately log-linear (due to the assumption of log-linearity in the IV analyses). However, 
as some associations between offspring BP and cause-specific mortality (CHD, stroke, breast cancer and 
prostate cancer, for example) showed a nonlinear pattern, interpretation and generalization of the IV 
approach may differ.
Despite these limitations, our current study had sufficient power to make reliable estimates of the 
likely causal association between BP and mortality, while adjusting for appropriate confounding fac-
tors and using family data to compare IV and conventional observational estimates. Although the IV 
approach produced considerably less precise estimates (wider CIs than in conventional observational 
analyses), using offspring BP as an instrument for own BP provided a more reliable estimate of the 
causal relationship between BP and mortality, without limitations inherent in conventional observational 
studies. Results are likely to be generalisable to other European populations, but may be less relevant for 
less developed or for ethnically diverse populations.
Results support the potentially causal role of elevated BP on all-cause mortality and mortality from 
CVD and CHD, elevated DBP and stroke mortality, and elevated SBP on mortality from diabetes. The 
positive association between elevated SBP and diabetes mortality attenuated upon adjustment for BMI, 
either suggesting that the relationship is, in part, mediated through BMI or there is an independent asso-
ciation between BMI and diabetes mortality. Therefore, clinical interventions to reduce diabetes mortality 
should potentially focus primarily on BMI. Importantly, using IV methodology, the previously reported 
U-shaped association between BP and mortality was not observed, suggesting that an increased mortality 
with lower levels of BP may be a result of reverse causation or confounding. As IV-estimated HRs were 
larger than those obtained from conventional Cox regression, taken together, these results highlight the 
adverse causal effect of high BP on later mortality risk.
www.nature.com/scientificreports/
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Methods
The HUNT Study is a large-scale prospective study of family and individual data on approximately 
125,000 individuals living in the rural Nord-Trøndelag County in central Norway. The data can be linked 
to national and regional health registries and contain additional information from The Population Census 
Register, National Population Registry and Family Register, which are provided by Statistics Norway 
to create a genealogical database and emigration status42. The Cause of Death Registry provided by 
Statistics Norway was used to identify all deaths among participants between the beginning of HUNT1 
(1st January 1984) and 31st December 2009, classified by cause according to their international classifica-
tion of diseases (ICD) code (Supplementary Table S17).
Methods and background of the HUNT study have been described previously42,43. The study consists of 
three consecutive surveys at which residents of aged 20 years and older were invited to participate. An ado-
lescent part (Young-HUNT Study) included people aged 13–19 years old was also conducted. In the first 
HUNT survey (HUNT1; 1984–1986), 74,599 individuals were successfully recruited (88.1% response rate). 
At the second survey (HUNT2; 1995–1997) questionnaire-based information and blood samples were 
obtained from approximately 65,000 individuals (69.5% response rate). In HUNT3 (2008), data were col-
lected through questionnaires, interviews, clinical examinations, and blood and urine samples from 48,289 
participants (52% response rate). Additionally, Young-HUNT44 included data from self-reported question-
naires, interviews, and clinical measurements: Young-HUNT1 (1995–1997; n = 9,141 (90% response rate)), 
Young-HUNT2 (2000–2001; n = 2,400 (77% response rate)), and Young-HUNT3 (2006–2008; n = 8,677 
(87% response rate)).
Initially, HUNT or Young-HUNT participants who had at least one participating parent were extracted 
(66,262 offspring, with 62,414 participating mothers and 53,145 participating fathers). Participants at 
every HUNT and Young-HUNT survey attended a physical examination, where SBP and DBP were 
measured. If individuals participated in multiple surveys, data from the earliest HUNT survey were used 
to maximise the period that parents were at risk and minimize the potential influence of illness-induced 
alteration of BP. Young-HUNT data were used for offspring only when no HUNT data were available, 
to increase sample size and minimize variation in BP due to different stages of adolescence. Data were 
restricted to one randomly chosen offspring per parent and, where possible, the same offspring was cho-
sen for both parents. Data were available for 32,227 mother-offspring pairs (15,941/16,286 daughters/
sons) and 27,535 father-offspring pairs (13,623/13,912 daughters/sons) (Supplementary Figure S1).
Statistical Analysis. The analyses were performed with primary focus on all-cause mortality and 
mortality specifically from CVD, CHD and stroke. Secondary analyses examined mortality from diabe-
tes, various cancers, respiratory diseases and external causes (presented in the Supplementary Material). 
Each measure of offspring and own BP was assigned to quintiles among participants of the same sex 
and similar age, in the same HUNT survey. Within these quintiles, we summarized offspring and own 
health-related characteristics and assessed the corresponding association with BP using linear and logis-
tic regression appropriately. As recommended by Tobin et al.45, we adjusted for the treatment effect of 
antihypertensives by adding 10 mmHg or 5 mmHg onto the SBP or DBP measurements, respectively, 
of individuals who self-reported taking BP-lowering medication before all analyses. Individuals with 
missing data on antihypertensive use were excluded (Supplementary Figure S1). As Young-HUNT par-
ticipants were not asked about medication, they were assumed not to be using antihypertensives due to 
their young age and were not excluded.
Before all analyses, offspring and own BP values were converted to sex-specific Z-scores, adjusted 
for age (cubic spline with five knots at the 5th, 27.5th, 50th, 72.5th, and 95th percentiles) interacting with 
HUNT survey (a categorical variable based on HUNT/Young-HUNT) We used the Cox proportional 
hazard model with own age as the time axis to estimate hazard ratios (HRs) per standard deviation (SD) 
increase in offspring and own HUNT survey- and age-adjusted BP. To account for clustering by offspring 
identity we used robust standard errors (SEs). All models were adjusted for own sex and date of birth 
(DOB; to account for secular trends in mortality). Fully-adjusted models additionally included own 
smoking status, alcohol consumption, education, exercise, own and spouse’s employment, and offspring’s 
smoking status. As unadjusted and fully-adjusted estimates were similar, only fully-adjusted models are 
presented (unadjusted analyses available on request). Heterogeneity between maternal and paternal HRs 
was tested by adding an interaction between parental sex and the exposure into the model and examin-
ing the p-value of the resulting coefficient. As there was little evidence for heterogeneity (Supplementary 
Tables S18/S19 for SBP/DBP, respectively), mothers and fathers were analysed together. Parent-specific 
analyses, not adjusted for parental sex and not requiring robust SEs, were conducted as a supplement.
To avoid reverse causation, IV analysis was used to estimate HRs per SD of own BP, using offspring 
BP as an IV for own BP (Supplementary Figure S2). Firstly, own BP was regressed on offspring BP, 
with adjustment for all covariables (own and parental smoking status, age, DOB, alcohol consumption, 
education, own and spouse’s employment exercise and sex of parent). The causal HRs per SD of own BP 
were then estimated by exponentiating the ratio between the natural logarithm of the corresponding HR 
per SD increase in offspring BP, obtained through conventional Cox regression with the same adjust-
ment, and the adjusted regression coefficient for own BP against offspring BP. Confidence intervals (CIs) 
were calculated using Taylor series expansions46. The HRs obtained through IV analyses were compared 
with conventional observational HRs per SD of own BP using 1,000 bootstrap samples. In a sensitivity 
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analysis, own BMI was added into fully-adjusted models. In a second sensitivity analysis, we excluded 
all individuals who self-reported taking antihypertensives (See Supplementary Methods for IV equation).
Linearity of associations was tested by plotting fully-adjusted cubic spline models for both offspring 
and own BP to show the pattern of association between BP and mortality. Observations were censored 
to restrict them to the period when death would have been recorded and used in the analysis of own BP 
and offspring BP. Analyses were performed using STATA versions 12 and 13 (Stat Corp, Texas).
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